Developing artificial intelligence software to streamline the diagnosis of blood cancers.
Spotlight Pathology has raised €2.1M across 2 funding rounds from 2 investors, most recently a Seed round in Mar 2026. Based in Manchester, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-03-11 | Seed | €1.6M | UK Innovation and Science Seed Fund (UKI2S) | View deal → |
| 2025-04-30 | Other | €499k | EHE Ventures | View deal → |
